Unconventional isoquinoline-based SERMs elicit fulvestrant-like transcriptional programs in ER+ breast cancer cells. - Hancock GR; Young KS; Hosfield DJ; Joiner C; Sullivan EA; Yildiz Y; Lainé M; Greene GL; Fanning SW (NPJ breast cancer, 2022)